Concepedia

Michael Y. Bonner

MY

22

Publications

1.6K

Citations

19

H-Index

2009

Active since

Affiliations

Emory University(Current)

Winship Cancer Institute

United States Department of Veterans Affairs

Johns Hopkins University

University of Maryland, Baltimore

Michael Y. Bonner is an author at Emory University specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2009–2021

22

Publications

22

Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial Sirt3

Vinodkumar B. Pillai, Sadhana Samant, Nagalingam R. Sundaresan et al. · Nature Communications · 2015 · 429 citations · Full text

Fulvene-5 potently inhibits NADPH oxidase 4 and blocks the growth of endothelial tumors in mice

Sulochana S. Bhandarkar, Marisa Jaconi, Levi Fried et al. · Journal of Clinical Investigation · 2009 · 112 citations · Full text

, , +17

Anti-Invasive Adjuvant Therapy with Imipramine Blue Enhances Chemotherapeutic Efficacy Against Glioma

Jennifer M. Munson, Levi Fried, Sydney A. Rowson et al. · Science Translational Medicine · 2012 · 111 citations

SIRT3 is attenuated in systemic sclerosis skin and lungs, and its pharmacologic activation mitigates organ fibrosis

Kaname Akamata, Jun Wei, Mitra Bhattacharyya et al. · Oncotarget · 2016 · 106 citations · Full text

Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis

Arumugam Nagalingam, Jack L. Arbiser, Michael Y. Bonner et al. · Breast Cancer Research · 2012 · 99 citations · Full text

Rows per page

1–5 of 22